Highline Wealth Partners’s Astrana Health ASTH Stock Holding History

Highline Wealth Partners’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31	Closed	-$961	–	1094
2025 Q1	$961	Buy	+31	New	+$1.03K	﹤0.01%	752

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Highline Wealth Partners's ASTH Position: Q2 2025 in Review

Highline Wealth Partners sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 31 shares — an estimated $961 sold.

Highline Wealth Partners first reported a position in ASTH in Q1 2025 and held it in 1 quarter. The position peaked at $961 in Q1 2025. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

Highline Wealth Partners reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
Highline Wealth Partners sold 31 Astrana Health shares in Q2 2025, an estimated $961.
Highline Wealth Partners first reported a position in Astrana Health in Q1 2025 and held it in 1 quarter.
Highline Wealth Partners's Astrana Health position peaked at $961 in Q1 2025.
162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on Highline Wealth Partners's 13F filing for Q2 2025, filed 16 Jul 2025.